Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targets and treatments in primary CNS lymphoma.
von Roemeling C, Ferreri AJM, Soussain C, Tun HW, Grommes C. von Roemeling C, et al. Among authors: grommes c. Leuk Lymphoma. 2024 Aug;65(8):1055-1067. doi: 10.1080/10428194.2024.2342560. Epub 2024 Apr 24. Leuk Lymphoma. 2024. PMID: 38659230 Review.
Consolidation Regimen and Cerebral Atrophy in Patients with Primary Central Nervous System Lymphoma.
Tringale KR, Grommes C, Ucpinar BA, Reiner AS, Yahalom J, Cederquist G, Schaff L, Hatzoglou V, Young RJ, Payinkay M, Bartlett G, Scordo M, Imber BS, Schefflein J. Tringale KR, et al. Among authors: grommes c. Int J Radiat Oncol Biol Phys. 2024 Nov 28:S0360-3016(24)03661-7. doi: 10.1016/j.ijrobp.2024.11.088. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39615656
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Grommes C, Nandakumar S, Schaff LR, Gavrilovic I, Kaley TJ, Nolan CP, Stone J, Thomas AA, Tang SS, Wolfe J, Bozza A, Wongchai V, Hyde A, Barrett E, Lynch EA, Madzsar JT, Lin A, Piotrowski AF, Pentsova E, Francis JH, Hatzoglou V, Schultz N, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK. Grommes C, et al. Clin Cancer Res. 2024 Sep 13;30(18):4005-4015. doi: 10.1158/1078-0432.CCR-24-0605. Clin Cancer Res. 2024. PMID: 38995739 Clinical Trial.
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma.
Schaff LR, Carlow D, Schofield R, Wongchai V, Madzsar J, Hyde A, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK, Lobbous M, Nabors LB, Grommes C. Schaff LR, et al. Among authors: grommes c. JCO Oncol Pract. 2024 Oct;20(10):1384-1390. doi: 10.1200/OP.24.00080. Epub 2024 Jun 25. JCO Oncol Pract. 2024. PMID: 38917404 Free PMC article. Clinical Trial.
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas.
Cederquist GY, Schefflein J, Devlin SM, Shah GL, Shouval R, Hubbeling H, Tringale K, Alarcon Tomas A, Fregonese B, Hajj C, Boardman A, Luna De Abia A, Corona M, Cassanello G, Dahi PB, Lin RJ, Ghione P, Salles G, Perales MA, Palomba ML, Falchi L, Scordo M, Grommes C, Yahalom J, Imber BS. Cederquist GY, et al. Among authors: grommes c. Blood Adv. 2024 Oct 8;8(19):5192-5199. doi: 10.1182/bloodadvances.2024013393. Blood Adv. 2024. PMID: 38861344 Free PMC article.
87 results